Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Return on Capital Employed [ROCE] (2024 - 2026)

Updated

Pelthos Therapeutics (PTHS) posted Return on Capital Employed [ROCE] of -52.81% for Q2 2026, down 14.11 percentage points from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends

For FY2025, Pelthos Therapeutics' Return on Capital Employed [ROCE] came in at -81.30%.

  • Quarterly Return on Capital Employed [ROCE] has run from a low of -1668.73% in Q2 2024 to a high of -31.66% in Q4 2025 over five years.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -38.70% (Q1 2026), -31.66% (Q4 2025) and -57.26% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Pelthos Therapeutics 77.24 Mn -11.16 Mn 11.99 Mn -52.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.81%
Mar 31, 2026 -38.70%
Dec 31, 2025 -31.66%
Sep 30, 2025 -57.26%
Jun 30, 2024 -1,668.73%
API Access

Pelthos Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PTHS&period=max&api_key=YOUR_API_KEY